Dynamics of macrophage trogocytosis of rituximab-coated B cells

Autor: Patricia Mero, Theodore Pham, James W. Booth
Jazyk: angličtina
Rok vydání: 2011
Předmět:
Trogocytosis
media_common.quotation_subject
Immunology/Innate Immunity
lcsh:Medicine
Cell Biology/Cell Signaling
Flow cytometry
Cell Line
03 medical and health sciences
Antibodies
Monoclonal
Murine-Derived

Mice
0302 clinical medicine
Antigen
Cell Biology/Membranes and Sorting
Cell Biology/Cytoskeleton
medicine
Macrophage
Animals
Cell Biology/Leukocyte Signaling and Gene Expression
Internalization
Oncology/Hematological Malignancies
lcsh:Science
Cell Shape
030304 developmental biology
media_common
0303 health sciences
B-Lymphocytes
Multidisciplinary
medicine.diagnostic_test
biology
Macrophages
lcsh:R
Opsonin Proteins
Antigens
CD20

Flow Cytometry
Molecular biology
3. Good health
Cell biology
Kinetics
Cell culture
Immunology/Leukocyte Activation
biology.protein
Rituximab
lcsh:Q
Antibody
030215 immunology
medicine.drug
Research Article
Zdroj: PLoS ONE, Vol 6, Iss 1, p e14498 (2011)
PLoS ONE
ISSN: 1932-6203
Popis: Macrophages can remove antigen from the surface of antibody-coated cells by a process termed trogocytosis. Using live cell microscopy and flow cytometry, we investigated the dynamics of trogocytosis by RAW264.7 macrophages of Ramos B cells opsonized with the anti-CD20 monoclonal antibody rituximab. Spontaneous and reversible formation of uropods was observed on Ramos cells, and these showed a strong enrichment in rituximab binding. RAW-Ramos conjugate interfaces were highly enriched in rituximab, and transfer of rituximab to the RAW cells in submicron-sized puncta occurred shortly after cell contact. Membrane from the target cells was concomitantly transferred along with rituximab to a variable extent. We established a flow cytometry-based approach to follow the kinetics of transfer and internalization of rituximab. Disruption of actin polymerization nearly eliminated transfer, while blocking phosphatidylinositol 3-kinase activity only resulted in a delay in its acquisition. Inhibition of Src family kinase activity both slowed acquisition and reduced the extent of trogocytosis. The effects of inhibiting these kinases are likely due to their role in efficient formation of cell-cell conjugates. Selective pre-treatment of Ramos cells with phenylarsine oxide blocked uropod formation, reduced enrichment of rituximab at cell-cell interfaces, and reduced the efficiency of trogocytic transfer of rituximab. Our findings highlight that dynamic changes in target cell shape and surface distribution of antigen may significantly influence the progression and extent of trogocytosis. Understanding the mechanistic determinants of macrophage trogocytosis will be important for optimal design of antibody therapies.
Databáze: OpenAIRE